CAS106021-96-9;β-Interleukin I (163-171), Huma

Send Inquiry
CAS106021-96-9;β-Interleukin I (163-171), Huma
Details
CAS: 106021-96-9
Sequence: Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys (VQGEESNDK, fragment 163-171 of human IL-1β)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Immunopeptide / Vaccine Adjuvant Short Peptide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas106021-96-9;β-interleukin i (163-171), huma in China, also supports custom service. Welcome to wholesale bulk high quality cas106021-96-9;β-interleukin i (163-171), huma from our factory. Contact us for more details.

 

Product name β-Interleukin I (163-171), human
CAS 106021-96-9
Description Also known as Sclavo peptide, it is an immunostimulatory nonapeptide fragment derived from human IL-1β. It does not bind to IL-1 receptors and acts as a safe immune adjuvant to enhance T cell immune responses, applied in vaccine development, tumor immunity and immune regulation mechanism research.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₃₉H₆₄N₁₂O₁₉
Molecular weight (Da) 1004.99
Terminal modifications Native free termini, no chemical modifications

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
β-Interleukin I (163-171), human Human IL-1β fragment 163-171; Sclavo peptide; CAS 106021-96-9; Immune adjuvant peptide Immunostimulatory peptide,T cell activation,Vaccine adjuvant,IL-1β derived fragment,Inflammation regulation study,Antigen presentation enhancement Valine-glutamine-glycine-glutamic acid-glutamic acid-serine-asparagine-aspartic acid-lysine C₃₉H₆₄N₁₂O₁₉ 1004.44 1004.99 Free amine, no modification Free carboxyl, no modification 9

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-IL1B001 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid repeated freeze-thaw cycles Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare aqueous solutions freshly before use Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots; stable for 6 months at -80℃ in aliquots. **Excellent water solubility, freely soluble in water and physiological buffer**. Unmodified short peptide is easily degraded by peptidases with poor room-temperature stability Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-IL1B001 Human IL-1β-derived nonapeptide immune adjuvant fragment that enhances T cell immune responses with no proinflammatory side effects β-Interleukin I (163-171) is a synthetic nonapeptide derived from residues 163-171 of human interleukin-1β (IL-1β), also known as Sclavo peptide. This fragment does not bind to IL-1 receptors and lacks the proinflammatory activity of the full cytokine, but acts as a potent immunostimulatory adjuvant that significantly enhances antigen-specific T cell responses, promotes activation and proliferation of CD4+ helper T cells and CD8+ cytotoxic T cells, and synergistically boosts humoral and cellular immunity. Its mechanism of action is independent of the IL-1R signaling pathway, with minimal proinflammatory side effects and high safety. It is widely used in vaccine adjuvant development, tumor immunotherapy research, immune regulation mechanism analysis, antigen presentation mechanism research and infection immunity evaluation. Vaccine adjuvant development,Tumor immunity research,Immune regulation mechanism study,T cell activation research,Antigen presentation mechanism study,Infection immunity research T cell activation pathway; Antigen presentation auxiliary pathway; Immune adjuvant effect pathway

Hot Tags: cas106021-96-9;β-interleukin i (163-171), huma, China cas106021-96-9;β-interleukin i (163-171), huma manufacturers, suppliers, factory, 121062-08-6, BPC 157, CAS 2381089 83 2, CAS 910463 68 2, Selank, Semaglutide

Send Inquiry